Denise Globe

4.5k total citations
106 papers, 3.6k citations indexed

About

Denise Globe is a scholar working on Rheumatology, Hematology and Urology. According to data from OpenAlex, Denise Globe has authored 106 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Rheumatology, 25 papers in Hematology and 18 papers in Urology. Recurrent topics in Denise Globe's work include Pelvic floor disorders treatments (21 papers), Urinary Bladder and Prostate Research (18 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Denise Globe is often cited by papers focused on Pelvic floor disorders treatments (21 papers), Urinary Bladder and Prostate Research (18 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Denise Globe collaborates with scholars based in United States, United Kingdom and Australia. Denise Globe's co-authors include Nishan Sengupta, Michael B. Nichol, Patrick W. Sullivan, Vahram Ghushchyan, Shao‐Lee Lin, Kathleen Meeske, Kristin Khalaf, Xingyue Huang, Michael B. Chancellor and Gary Globe and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Denise Globe

104 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Globe United States 37 855 607 571 501 483 106 3.6k
Michael B. Nichol United States 32 546 0.6× 500 0.8× 500 0.9× 414 0.8× 149 0.3× 119 4.2k
Andrew P. Yu United States 33 433 0.5× 1.1k 1.8× 129 0.2× 254 0.5× 302 0.6× 80 3.7k
S. P. McKenna United Kingdom 19 611 0.7× 464 0.8× 81 0.1× 210 0.4× 305 0.6× 29 4.1k
Margaret C. Reilly United States 17 506 0.6× 544 0.9× 78 0.1× 236 0.5× 483 1.0× 34 3.6k
Kathleen Beusterien United States 31 260 0.3× 445 0.7× 101 0.2× 219 0.4× 140 0.3× 101 3.2k
Joris van der Post Netherlands 51 543 0.6× 831 1.4× 164 0.3× 516 1.0× 167 0.3× 234 8.7k
Arthur S. Zbrozek United States 16 358 0.4× 484 0.8× 65 0.1× 150 0.3× 346 0.7× 27 3.3k
Hein W. Bruinse Netherlands 42 1.0k 1.2× 737 1.2× 247 0.4× 408 0.8× 90 0.2× 171 5.2k
Tavs Folmer Andersen Denmark 16 298 0.3× 702 1.2× 424 0.7× 44 0.1× 126 0.3× 35 3.3k
Cheryl Barnabé Canada 36 1.9k 2.2× 457 0.8× 43 0.1× 540 1.1× 157 0.3× 200 4.0k

Countries citing papers authored by Denise Globe

Since Specialization
Citations

This map shows the geographic impact of Denise Globe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Globe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Globe more than expected).

Fields of papers citing papers by Denise Globe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Globe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Globe. The network helps show where Denise Globe may publish in the future.

Co-authorship network of co-authors of Denise Globe

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Globe. A scholar is included among the top collaborators of Denise Globe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Globe. Denise Globe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slagle, Ashley F., et al.. (2023). An Updated Review of Food and Drug Administration Warning and Untitled Letters for Clinical Outcome Assessment Claims Between 2013 and 2021. Value in Health. 26(12). 1675–1680. 1 indexed citations
2.
Mahesri, Mufaddal, Sebastian Schneeweiß, Denise Globe, et al.. (2020). Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrollees. European Journal Of Haematology. 106(2). 273–280. 7 indexed citations
3.
Bloudek, Lisa, Anuja Roy, Jonathan Kish, et al.. (2016). Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model. Journal of Managed Care & Specialty Pharmacy. 22(8). 991–1002. 7 indexed citations
4.
5.
Sullivan, Patrick W., Karen L. Smith, Vahram Ghushchyan, et al.. (2013). Asthma in USA: its impact on health-related quality of life. Journal of Asthma. 50(8). 891–899. 49 indexed citations
6.
Kay, Stephen, Keith Tolley, Danielle Colayco, et al.. (2013). Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder. Value in Health. 16(2). 394–402. 29 indexed citations
7.
Malone, Daniel C., et al.. (2013). Cost-effectiveness analyses for refractory overactive bladder: A systematic literature review. Value in Health. 16(3). A182–A182. 1 indexed citations
8.
Carlson, Josh J., Ryan N. Hansen, Roger R. Dmochowski, et al.. (2013). Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Clinical Therapeutics. 35(4). 414–424. 19 indexed citations
9.
Slejko, Julia F., et al.. (2013). Asthma control in the United States, 2008-2010: Indicators of poor asthma control. Journal of Allergy and Clinical Immunology. 133(6). 1579–1587. 81 indexed citations
10.
Carlson, Josh J., et al.. (2013). Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States. Value in Health. 16(3). A105–A105. 2 indexed citations
11.
Sussman, David, Vaishali Patel, Giulio Del Popolo, et al.. (2012). Treatment satisfaction and improvement in health‐related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. Neurourology and Urodynamics. 32(3). 242–249. 40 indexed citations
12.
Aledort, Louis M., Monika Bullinger, Sylvia von Mackensen, et al.. (2012). Why should we care about quality of life in persons with haemophilia?. Haemophilia. 18(3). e154–7. 35 indexed citations
13.
Barocas, Daniel A., et al.. (2011). PCN134 HUMANISTIC CONSEQUENCES OF PREVENTABLE BLADDER TUMOR RECURRENCES IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC). Value in Health. 14(3). A179–A179. 1 indexed citations
14.
Langley, Richard G., Amy S. Paller, Adelaide A. Hebert, et al.. (2010). Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. Journal of the American Academy of Dermatology. 64(1). 64–70. 58 indexed citations
15.
Meltzer, Eli O., William W. Busse, Sally E. Wenzel, et al.. (2010). Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. Journal of Allergy and Clinical Immunology. 127(1). 167–172. 91 indexed citations
16.
Watson, Crystal, et al.. (2010). Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis. Journal of Medical Economics. 13(2). 228–235. 9 indexed citations
17.
Brantingham, James W., et al.. (2009). A Feasibility Study Comparing Two Chiropractic Protocols in the Treatment of Patellofemoral Pain Syndrome. Journal of Manipulative and Physiological Therapeutics. 32(7). 536–548. 23 indexed citations
18.
Globe, Denise. (2005). Self-reported Comorbidities and Visual Function in a Population-Based Study. Archives of Ophthalmology. 123(6). 815–815. 42 indexed citations
19.
Globe, Denise. (2004). The impact of visual impairment on self-reported visual functioning in Latinos*1The Los Angeles Latino Eye Study. Ophthalmology. 111(6). 1141–1149. 74 indexed citations
20.
Nichol, Michael B., Nishan Sengupta, & Denise Globe. (2001). Evaluating Quality-Adjusted Life Years: Estimation of the Health Utility Index (HUI2) from the SF-36. Medical Decision Making. 21(2). 105–112. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael B. Nichol Breakdown of academic impact, for papers by Andrew P. Yu Breakdown of academic impact, for papers by S. P. McKenna Breakdown of academic impact, for papers by Margaret C. Reilly Breakdown of academic impact, for papers by Kathleen Beusterien Breakdown of academic impact, for papers by Joris van der Post Breakdown of academic impact, for papers by Arthur S. Zbrozek Breakdown of academic impact, for papers by Hein W. Bruinse Breakdown of academic impact, for papers by Tavs Folmer Andersen Breakdown of academic impact, for papers by Cheryl Barnabé
Rankless by CCL
2026